US$ 27.50
tirzepatide factory Bulk Supply Tirzepatide
Description
Rated 5 out of 5 Anonymous (verified owner) Rated 5 out of 5 Caitlin B

FDA approvals: Tirzepatide is uniquely approved for obstructive sleep apnea in adults with obesity (Zepbound, December 2024) the first medication ever approved for this indication

It is one of the primary reasons people regain weight after stopping GLP-1 medications

The same effect shows up with Mounjaro, which uses the identical active ingredient at the same doses Zepbound and Mounjaro share tirzepatide

Its reassuring to have medical expertise guiding my weight loss journey

Important: GLP-1 medications carry a boxed warning for thyroid C-cell tumors
